Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in Focus - Dalal Street Investment Journal
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in FocusDalal Street Investment Journal
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports
Markets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,000. Key stocks like Alkem Labs, Vedanta, Canara Bank, NHPC, and Adani Ports are in focus due to significant corporate developments including block deals, ED visits, capital raising plans, oversubscribed OFS, and strong cargo volumes.
Sensex falls 70 points, Nifty below 23,900 as US-Iran tensions simmer
Indian stock markets opened lower on Wednesday. Sensex and Nifty saw minor declines. Investors are watching US strikes on Iran and their effect on peace deal hopes. Broader markets are performing better. India VIX, a volatility measure, dropped. Top Sensex losers included HDFC Bank and Infosys. Sun Pharma shares led gains. Midcap and smallcap indices saw small gains.
Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.
Trade Setup for May 27: Nifty holds on to key levels as market moves from one expiry to another
The Nifty Bank was the key contributor in the Nifty exhibiting sluggish moves on expiry day, but unlike the Nifty, the banking index continued to trade in a broad range. Despite a 500-point fall from the day's high, the index managed to hold on to the 55,000 mark on a closing basis, something the bulls could take heart from. Tuesday's high of 55,536 will be the first level to watch on the upside.
STT hike, cooling volatility take a bite out of index options volumes
Average daily premium turnover for Nifty and Sensex options over 16 sessions in May was 13% below levels in March, the final month before the 50% STT hike took effect. Trading volumes were also impacted by a fall in volatility amid growing hopes of a US-Iran peace deal.
Pharma, healthcare stocks drag markets amid volatility; Nifty and Sensex close week in green
The equity benchmark indices closed in the green on Friday (May 22) but could not fully hold intraday gains, with Sensex rising 232 points to 75,415 and Nifty gaining 65 points to 23,719.
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescue - The Times of India
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescueThe Times of IndiaWhy is market falling today? Sensex falls 600 points, Nifty below 23,500; 5 key factors behind bloodbathThe Economic TimesSensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15%Equitymaster
Nifty above 23,500 level; pharma shares in demand
At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 228.50 points or 0.31% to 74,837.48. The Nifty 50 index rose 98.85 points or 0.42% to 23,511.40.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.